ClinicalTrials.Veeva

Menu

Impact of Graduation on Child Development in Uganda - Wave 2 (Ancillary/Extension)

I

Innovations for Poverty Action

Status

Active, not recruiting

Conditions

Anemia
School Readiness
Child Development
Under Nutrition

Treatments

Other: Graduation

Study type

Interventional

Funder types

Other

Identifiers

NCT07212374
AEARCTR-0004080 (Registry Identifier)
NCT05531812 (IPA-2022-UG) (Registry Identifier)
IPA-2025-UG-Wave2

Details and patient eligibility

About

This ancillary/extension study ("Wave 2") measures child development and school readiness outcomes among children residing in households within host communities that participated in the Graduation to Resilience (G2R) randomized controlled trial in Uganda (G2R trial: AEARCTR-0004080 [AEA RCT Registry]; Wave 1 child assessments: NCT05531812). No new randomization or intervention assignment occurs in Wave 2; rather, we assess outcomes in children linked to households in communities previously randomized in the parent study.

Wave 2 expands the eligible child age range (0-9 years) and includes age-appropriate outcomes (e.g., IDELA for school readiness; Raven's Progressive Matrices and executive function tasks for older children). We will compare children in households assigned to receive the Graduation program in the parent RCT (T1) to children in pure ("spillover") control households (C2) in host communities. Primary completion is anticipated in October 2025. Pre-analysis plans for Wave 1 and Wave 2 are posted.

Full description

Parent RCT & groups: The G2R trial used staged randomization at the community level. In Wave 2 we sample host-community households only, comparing:

T1 (Graduation): households in host communities assigned to receive the Graduation program in the parent trial;

C2 (pure "spillover" control): households in host control communities.

Wave 2 purpose: To measure child development and school readiness outcomes in an expanded age range (0-9 years) using validated, age-appropriate instruments.

Design note: Wave 2 is observational with exposure defined by prior random assignment in the parent RCT; there is no new assignment of interventions in Wave 2.

Documents: The Pre-Analysis Plan (PAP) for this Wave 2 is available under Study Documents and cross-references the PAP from Wave 1 (NCT05531812).

Linkage to parent study: This record is explicitly linked to NCT05531812 and AEARCTR-0004080 [AEA RCT Registry].

Enrollment

2,100 estimated patients

Sex

All

Ages

6 to 119 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Child aged 0-9 years at time of Wave 2 assessment.
  • Resides in a host-community household within the G2R trial sample
  • Caregiver provides informed consent; child provides assent where applicable.

Exclusion criteria

  • Caregiver declines consent or child declines assent.
  • Not resident in the study communities at time of assessment.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

2,100 participants in 2 patient groups

Pure ("Spillover") Control (C2)
No Intervention group
Description:
Children aged 0-9 years living in host-community households in pure control communities (no Graduation program) from the parent RCT
Graduation (T1)
Experimental group
Description:
Children aged 0-9 years living in host-community households assigned to receive the Graduation program in the parent RCT (no new assignment in Wave 2).
Treatment:
Other: Graduation

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems